Kabigef 250mg Tablet
Marketer
Fresenius Kabi India Pvt Ltd
Salt Composition
Gefitinib (250mg)
Overview Kabigef 250mg Tablet
Afgeka 250mg tablets treat advanced non-small cell lung cancer. This medication is prescribed for patients with metastatic disease, abnormal epidermal growth factor receptor (EGFR) genes, and no prior cancer therapy. Dosage and treatment duration are determined by your physician. Regular liver function monitoring may be advised. Common side effects include nausea, diarrhea, dry skin, and appetite loss. Increased fluid intake may help mitigate these effects. Report any concerning or worsening side effects to your doctor. Immediately report mouth sores, vision changes, or breathing problems. Women should utilize effective contraception throughout treatment and for one month post-treatment to prevent pregnancy. Disclose all other medications you are currently using to your physician.
Primary Ingredients of Kabigef 250mg Tablet
No information provided. Unable to rephrase.
Uses of Kabigef 250mg Tablet
Lung cancer (excluding small cell)
Major Benefits of Kabigef 250mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Kabigef 250mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Kabigef 250mg Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Kabigef 250mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Kabigef 250mg Tablets can be consumed with or without food, however, consistent daily timing is recommended for optimal results.
How Kabigef 250mg Tablet works:
Oncasin 250mg tablets are an antineoplastic agent. Their mechanism of action involves inhibiting the activity of a faulty protein responsible for cancer cell proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Kabigef 250mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Kabigef 250mg tablets during pregnancy poses a confirmed risk to the fetus. Its use is contraindicated except in rare, life-threatening circumstances where the potential benefits outweigh the known dangers. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
The use of Kabigef 250mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Kabigef 250mg Tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Kabigef 250mg tablets cautiously. Dosage modification for Kabigef 250mg tablets may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Kabigef 250mg tablets are likely safe for individuals with liver conditions. Existing evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
What if you forget to take Kabigef 250mg Tablet :
Omit any missed Kabigef 250mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Kabigef 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
3,018 People bought this recently